<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-29T08:19:31Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/11364" metadataPrefix="qdc">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/11364</identifier><datestamp>2026-02-16T08:59:30Z</datestamp><setSpec>com_10259_4725</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_4726</setSpec></header><metadata><qdc:qualifieddc xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
<dc:title>Self-Reported Post-COVID Symptoms at 18 Months After Infection Among Adults in Southern Brazil: A Cross-Sectional Study</dc:title>
<dc:creator>Brito, Franciele Aline Machado de</dc:creator>
<dc:creator>Laranjeira, Carlos</dc:creator>
<dc:creator>Moroskoski, Márcia</dc:creator>
<dc:creator>Salci, Maria Aparecida</dc:creator>
<dc:creator>Rossoni, Stéfane Lele</dc:creator>
<dc:creator>Baccon, Wanessa Cristina</dc:creator>
<dc:creator>Oliveira, Rosana Rosseto de</dc:creator>
<dc:creator>Marques, Priscila Garcia</dc:creator>
<dc:creator>Góes, Herbert Leopoldo de Freitas</dc:creator>
<dc:creator>Mello, Fernanda Fontes</dc:creator>
<dc:creator>Blaszczak, Flávia Renata Baldissera da Cruz</dc:creator>
<dc:creator>Vissoci, João Ricardo Nickenig</dc:creator>
<dc:creator>Puente Alcaraz, Jesús</dc:creator>
<dc:creator>Facchini, Luiz Augusto</dc:creator>
<dc:creator>Carreira, Lígia</dc:creator>
<dc:subject>SARS-CoV-2</dc:subject>
<dc:subject>Long Covid</dc:subject>
<dc:subject>Signs and symptoms</dc:subject>
<dc:subject>Cross-sectional</dc:subject>
<dc:subject>Brazil</dc:subject>
<dcterms:abstract>Background/Objectives: Currently, there is a limited understanding of the long-term consequences following acute COVID-19, referred to as long COVID. This cross-sectional study aims to analyze the prevalence of persistent signs and symptoms of long COVID, 18 months after primary SARS-CoV-2 infection in adults in southern Brazil. Methods: Using two national databases (the digital registry of SARS-CoV-2 positive cases), 370 individuals living in the state of Paraná (Brazil) were recruited. Data were collected through telephone interviews conducted in 2021 and 2022. Results: The overall prevalence of long COVID was 66.2% among study participants. During the acute phase of infection, the most common symptom clusters included neurological symptoms (87.0%; n = 318), followed by respiratory (82.0%; n = 301), musculoskeletal (66.0%; n = 241), digestive (50.0%; n = 184), psychological (38.0%; n = 138), and endocrine symptoms (28.0%; n = 104). In the 18 month follow-up, the main persistent symptoms were memory loss (42.7%), fatigue (32.2%), anxiety (23.5%), dyspnea (19.7%), and hair loss (19.7%). The proportion of participants with long COVID was statistically higher in females (73.9%), those with a family income below two minimum wages (94.7%), those who do not practice physical activity (83.3%), those who report poor sleep quality (93.3%), those who use long-term medication (85.9%), those who needed health care in the previous six months (87.3%), those who required professional and/or family care (79.3%), those who were in the ICU (79.0%), and those who used ventilatory support (77.5%). Conclusions: Long COVID is a complex condition that requires long-term monitoring and investment in health services due to its high prevalence and the health consequences in the population.</dcterms:abstract>
<dcterms:dateAccepted>2026-02-12T10:15:09Z</dcterms:dateAccepted>
<dcterms:available>2026-02-12T10:15:09Z</dcterms:available>
<dcterms:created>2026-02-12T10:15:09Z</dcterms:created>
<dcterms:issued>2025-01</dcterms:issued>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:identifier>https://hdl.handle.net/10259/11364</dc:identifier>
<dc:identifier>10.3390/healthcare13030228</dc:identifier>
<dc:identifier>2227-9032</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Healthcare. 2025, V. 13, n. 3, p. 228-243</dc:relation>
<dc:relation>https://doi.org/10.3390/healthcare13030228</dc:relation>
<dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:rights>Atribución 4.0 Internacional</dc:rights>
<dc:publisher>MDPI</dc:publisher>
</qdc:qualifieddc></metadata></record></GetRecord></OAI-PMH>